Exicure Inc (XCUR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.80
• Market Cap: $24.16M
• EPS: $-3.72
• 52-Week High: $15.91
• 52-Week Low: $3.10

Market Sentiment

Exicure Inc currently has a Neutral sentiment score of -0.14.

About Exicure Inc

Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, focused on pioneering therapies through its proprietary spherical nucleic acid (SNA) technology. The company's robust pipeline targets a range of serious conditions, encompassing neurological disorders, immuno-oncology, inflammatory diseases, and genetic disorders. By harnessing its innovative SNA technology, Exicure is not only aiming to transform treatment paradigms but also to lead the advancement of RNA-ba...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Exicure Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XCUR pay dividends?

Exicure Inc (XCUR) does not currently pay a regular dividend.

What is XCUR's market cap?

Exicure Inc (XCUR) has a market capitalization of $24.16M with a current stock price of $3.80.